vs

UiPath, Inc.(PATH)与Tilray Brands, Inc.(TLRY)财务数据对比。点击上方公司名可切换其他公司

UiPath, Inc.的季度营收约是Tilray Brands, Inc.的1.9倍($411.1M vs $217.5M),UiPath, Inc.净利率更高(48.4% vs -20.7%,领先69.0%),UiPath, Inc.同比增速更快(15.9% vs 3.1%),过去两年Tilray Brands, Inc.的营收复合增速更高(7.5% vs 0.7%)

UiPath是一家全球化软件企业,专注于开发人工智能、智能自动化及流程编排类软件,其产品支持用户搭建与调度AI代理,实现复杂业务流程、工作流的自动化运行,助力各行业客户提升运营效率、降低人力成本。

Tilray Brands, Inc.是一家美国企业,主营医药、大麻生活方式产品以及包装消费品业务,公司注册于美国,总部坐落于纽约。该公司在加拿大、澳大利亚、新西兰、拉美地区均开展业务,同时在德国和葡萄牙拥有大麻种植基地。

PATH vs TLRY — 直观对比

营收规模更大
PATH
PATH
是对方的1.9倍
PATH
$411.1M
$217.5M
TLRY
营收增速更快
PATH
PATH
高出12.8%
PATH
15.9%
3.1%
TLRY
净利率更高
PATH
PATH
高出69.0%
PATH
48.4%
-20.7%
TLRY
两年增速更快
TLRY
TLRY
近两年复合增速
TLRY
7.5%
0.7%
PATH

损益表 — Q3 FY2026 vs Q2 FY2026

指标
PATH
PATH
TLRY
TLRY
营收
$411.1M
$217.5M
净利润
$198.8M
$-44.9M
毛利率
83.3%
26.4%
营业利润率
3.2%
-10.2%
净利率
48.4%
-20.7%
营收同比
15.9%
3.1%
净利润同比
1966.2%
47.4%
每股收益(稀释后)
$0.37
$-0.41

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
PATH
PATH
TLRY
TLRY
Q4 25
$411.1M
$217.5M
Q3 25
$361.7M
$209.5M
Q2 25
$356.6M
$224.5M
Q1 25
$423.6M
$185.8M
Q4 24
$354.7M
$210.9M
Q3 24
$316.3M
$200.0M
Q2 24
$335.1M
$229.9M
Q1 24
$405.3M
$188.3M
净利润
PATH
PATH
TLRY
TLRY
Q4 25
$198.8M
$-44.9M
Q3 25
$1.6M
$-322.0K
Q2 25
$-22.6M
$-1.3B
Q1 25
$51.8M
$-789.4M
Q4 24
$-10.7M
$-85.3M
Q3 24
$-86.1M
$-39.2M
Q2 24
$-28.7M
$-31.7M
Q1 24
$33.9M
$-92.7M
毛利率
PATH
PATH
TLRY
TLRY
Q4 25
83.3%
26.4%
Q3 25
82.2%
27.4%
Q2 25
82.1%
30.1%
Q1 25
84.8%
28.0%
Q4 24
82.0%
29.0%
Q3 24
80.0%
29.8%
Q2 24
83.5%
35.8%
Q1 24
86.8%
26.2%
营业利润率
PATH
PATH
TLRY
TLRY
Q4 25
3.2%
-10.2%
Q3 25
-5.6%
1.0%
Q2 25
-4.6%
-643.1%
Q1 25
7.9%
-409.0%
Q4 24
-12.2%
-20.0%
Q3 24
-32.7%
-18.3%
Q2 24
-14.8%
-7.2%
Q1 24
3.7%
-43.6%
净利率
PATH
PATH
TLRY
TLRY
Q4 25
48.4%
-20.7%
Q3 25
0.4%
-0.2%
Q2 25
-6.3%
-566.9%
Q1 25
12.2%
-424.9%
Q4 24
-3.0%
-40.5%
Q3 24
-27.2%
-19.6%
Q2 24
-8.6%
-13.8%
Q1 24
8.4%
-49.2%
每股收益(稀释后)
PATH
PATH
TLRY
TLRY
Q4 25
$0.37
$-0.41
Q3 25
$0.00
$0.00
Q2 25
$-0.04
$7.26
Q1 25
$0.09
$-8.69
Q4 24
$-0.02
$-0.99
Q3 24
$-0.15
$-0.04
Q2 24
$-0.05
$-0.04
Q1 24
$0.07
$-0.12

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
PATH
PATH
TLRY
TLRY
现金及短期投资手头流动性
$1.4B
$291.6M
总债务越低越好
股东权益账面价值
$1.9B
$1.6B
总资产
$2.9B
$2.1B
负债/权益比越低杠杆越低

8季度趋势,按日历期对齐

现金及短期投资
PATH
PATH
TLRY
TLRY
Q4 25
$1.4B
$291.6M
Q3 25
$1.4B
$264.8M
Q2 25
$1.6B
$256.4M
Q1 25
$1.6B
Q4 24
$1.6B
$252.2M
Q3 24
$1.7B
$280.1M
Q2 24
$1.9B
$260.5M
Q1 24
$1.9B
$225.9M
股东权益
PATH
PATH
TLRY
TLRY
Q4 25
$1.9B
$1.6B
Q3 25
$1.7B
$1.5B
Q2 25
$1.7B
$1.5B
Q1 25
$1.8B
$2.7B
Q4 24
$1.7B
$3.5B
Q3 24
$1.8B
$3.5B
Q2 24
$2.0B
$3.4B
Q1 24
$2.0B
$3.4B
总资产
PATH
PATH
TLRY
TLRY
Q4 25
$2.9B
$2.1B
Q3 25
$2.6B
$2.1B
Q2 25
$2.6B
$2.1B
Q1 25
$2.9B
Q4 24
$2.7B
$4.2B
Q3 24
$2.7B
$4.3B
Q2 24
$2.8B
$4.2B
Q1 24
$3.0B
$4.2B

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
PATH
PATH
TLRY
TLRY
经营现金流最新季度
$28.3M
$-8.5M
自由现金流经营现金流 - 资本支出
$25.1M
自由现金流率自由现金流/营收
6.1%
资本支出强度资本支出/营收
0.8%
现金转化率经营现金流/净利润
0.14×
过去12个月自由现金流最近4个季度

8季度趋势,按日历期对齐

经营现金流
PATH
PATH
TLRY
TLRY
Q4 25
$28.3M
$-8.5M
Q3 25
$41.6M
$-1.3M
Q2 25
$119.0M
$-12.8M
Q1 25
$146.1M
$-5.8M
Q4 24
$28.1M
$-40.7M
Q3 24
$46.4M
$-35.3M
Q2 24
$100.0M
$30.7M
Q1 24
$145.6M
$-15.4M
自由现金流
PATH
PATH
TLRY
TLRY
Q4 25
$25.1M
Q3 25
Q2 25
$106.2M
$-19.1M
Q1 25
$138.7M
$-20.2M
Q4 24
$23.2M
$-46.2M
Q3 24
$45.0M
$-42.0M
Q2 24
$98.8M
$21.0M
Q1 24
$141.8M
$-24.9M
自由现金流率
PATH
PATH
TLRY
TLRY
Q4 25
6.1%
Q3 25
Q2 25
29.8%
-8.5%
Q1 25
32.7%
-10.9%
Q4 24
6.5%
-21.9%
Q3 24
14.2%
-21.0%
Q2 24
29.5%
9.1%
Q1 24
35.0%
-13.2%
资本支出强度
PATH
PATH
TLRY
TLRY
Q4 25
0.8%
Q3 25
0.0%
Q2 25
3.6%
2.8%
Q1 25
1.7%
7.8%
Q4 24
1.4%
2.6%
Q3 24
0.4%
3.4%
Q2 24
0.4%
4.2%
Q1 24
0.9%
5.1%
现金转化率
PATH
PATH
TLRY
TLRY
Q4 25
0.14×
Q3 25
26.25×
Q2 25
Q1 25
2.82×
Q4 24
Q3 24
Q2 24
Q1 24
4.29×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

PATH
PATH

Subscription Services$247.6M60%
License$150.0M36%
Professional Services And Other$13.5M3%

TLRY
TLRY

Adultuse Cannabis Products$62.4M29%
Other$59.2M27%
Beverage Alcohol Business$53.6M25%
International Cannabis Products$20.2M9%
Wellness Business$14.6M7%
Medical Cannabis Products$6.2M3%
Wholesale Cannabis Products$1.3M1%

相关对比